Over the past 12 months, 7 insiders at Neumora Therapeutics, Inc. filed 8 open-market SEC Form 4 transactions on NMRA: 3 purchases worth $15.0M and 5 sales worth $390K. Insiders have been net sellers over this period. The most recent filing was on Feb 17, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 17, 26 | Daljit Singh AuroraSee Remarks | SELL | 6.2K | $3.56 | $22K |
| Feb 17, 26 | Paul L BernsSee Remarks | SELL | 9.8K | $3.51 | $34K |
| Feb 17, 26 | Michael Lee MilliganSee Remarks | SELL | 1.4K | $3.57 | $5K |
| Feb 17, 26 | Joshua PintoPresident | SELL | 6.0K | $3.54 | $21K |
| Nov 11, 25 | Daljit Singh AuroraSee Remarks | SELL | 114.7K | $2.68 | $307K |
| Oct 27, 25 | Arch Venture Partners Viii, LlcTenPercentOwner | BUY | 1.92M | $2.61 | $5.0M |
| Oct 27, 25 | Arch Venture Partners Xii, LlcTenPercentOwner | BUY | 1.92M | $2.61 | $5.0M |
| Oct 27, 25 | Kristina BurowDirector,TenPercentOwner | BUY | 1.92M | $2.61 | $5.0M |
| Feb 18, 25 | Daljit Singh AuroraChief Strategy Officer | SELL | 8.6K | $1.68 | $14K |
| Feb 18, 25 | Paul L BernsSee Remarks | SELL | 13.9K | $1.69 | $23K |
| Feb 18, 25 | Robert A. LenzHead of R&D | SELL | 5.6K | $1.67 | $9K |
| Feb 18, 25 | Michael Lee MilliganSee Remarks | SELL | 2.0K | $1.69 | $3K |
| Feb 18, 25 | Joshua PintoPresident | SELL | 8.0K | $1.67 | $13K |
| Oct 18, 24 | Matthew K FustDirector | SELL | 14.0K | $17.03 | $239K |
| Oct 17, 24 | Matthew K FustDirector | SELL | 7.7K | $17.01 | $132K |
| Oct 10, 24 | Robert A. LenzHead of R&D | SELL | 8.3K | $15.09 | $125K |
| Oct 9, 24 | Robert A. LenzHead of R&D | SELL | 5.6K | $15.01 | $84K |
| Sep 18, 24 | Robert A. LenzHead of R&D | SELL | 10.7K | $12.09 | $129K |
| Sep 17, 24 | Robert A. LenzHead of R&D | SELL | 30.8K | $11.81 | $364K |
| Sep 12, 24 | Robert A. LenzHead of R&D | SELL | 32.9K | $11.43 | $377K |
| Aug 27, 24 | Joshua PintoChief Financial Officer | SELL | 15.7K | $11.39 | $179K |
| Aug 26, 24 | Joshua PintoChief Financial Officer | SELL | 31.6K | $11.78 | $373K |
| Aug 23, 24 | Joshua PintoChief Financial Officer | SELL | 24.2K | $11.59 | $280K |
| Aug 22, 24 | Joshua PintoChief Financial Officer | SELL | 28.5K | $11.63 | $331K |
| Nov 14, 23 | Arch Venture Fund Xii, L.p.TenPercentOwner | BUY | 3.4K | $11.98 | $40K |
| Nov 14, 23 | Kristina BurowDirector,TenPercentOwner | BUY | 3.4K | $11.98 | $40K |
| Nov 13, 23 | Arch Venture Fund Xii, L.p.TenPercentOwner | BUY | 31.7K | $11.75 | $372K |
| Nov 13, 23 | Kristina BurowDirector,TenPercentOwner | BUY | 31.7K | $11.75 | $372K |
| Nov 10, 23 | Arch Venture Fund Xii, L.p.TenPercentOwner | BUY | 11.8K | $11.75 | $135K |
| Nov 10, 23 | Kristina BurowDirector,TenPercentOwner | BUY | 11.8K | $11.75 | $135K |
| Nov 9, 23 | Arch Venture Fund Xii, L.p.TenPercentOwner | BUY | 31.1K | $10.53 | $327K |
| Nov 9, 23 | Kristina BurowDirector,TenPercentOwner | BUY | 31.1K | $10.53 | $327K |
| Nov 8, 23 | Arch Venture Fund Xii, L.p.TenPercentOwner | BUY | 69.1K | $11.79 | $745K |
| Nov 8, 23 | Kristina BurowDirector,TenPercentOwner | BUY | 69.1K | $11.79 | $745K |
| Nov 7, 23 | Arch Venture Partners Xii, LlcTenPercentOwner | BUY | 30.2K | $11.50 | $347K |
| Nov 7, 23 | Kristina BurowDirector,TenPercentOwner | BUY | 30.2K | $11.50 | $347K |
| Nov 6, 23 | Arch Venture Partners Xii, LlcTenPercentOwner | BUY | 43.1K | $11.55 | $498K |
| Nov 6, 23 | Kristina BurowDirector,TenPercentOwner | BUY | 43.1K | $11.55 | $498K |
| Nov 3, 23 | Arch Venture Partners Xii, LlcTenPercentOwner | BUY | 22.4K | $11.38 | $255K |
| Nov 3, 23 | Kristina BurowDirector,TenPercentOwner | BUY | 22.4K | $11.38 | $255K |
| Sep 29, 23 | Kristina BurowDirector,TenPercentOwner | BUY | 34.6K | $13.98 | $483K |
| Sep 29, 23 | Robert NelsenTenPercentOwner | BUY | 34.6K | $13.98 | $483K |
| Sep 28, 23 | Kristina BurowDirector,TenPercentOwner | BUY | 25.1K | $13.69 | $344K |
| Sep 28, 23 | Robert NelsenTenPercentOwner | BUY | 25.1K | $13.69 | $344K |
| Sep 27, 23 | Kristina BurowDirector,TenPercentOwner | BUY | 24.5K | $12.31 | $302K |
| Sep 27, 23 | Robert NelsenTenPercentOwner | BUY | 24.5K | $12.31 | $302K |
| Sep 26, 23 | Kristina BurowDirector,TenPercentOwner | BUY | 34.0K | $11.73 | $399K |
| Sep 26, 23 | Robert NelsenTenPercentOwner | BUY | 34.0K | $11.73 | $399K |
| Sep 25, 23 | Kristina BurowDirector,TenPercentOwner | BUY | 30.8K | $11.65 | $349K |
| Sep 25, 23 | Robert NelsenTenPercentOwner | BUY | 30.8K | $11.65 | $349K |
Over the past 12 months, insiders at Neumora Therapeutics, Inc. filed 3 open-market purchases worth $15.0M and 5 sales worth $390K on NMRA, which makes them net sellers over the period. The most recent Form 4 was filed on Feb 17, 26.
The largest recent open-market NMRA insider purchase in our data was $5.0M by Arch Venture Partners Viii, Llc, TenPercentOwner, filed on Oct 27, 25.
7 different insiders at Neumora Therapeutics, Inc. filed open-market SEC Form 4 transactions on NMRA over the last 12 months.
InsiderTape plots every NMRA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Neumora Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →